Browse > Article
http://dx.doi.org/10.6116/kjh.2010.25.1.065

Inhibitory Effects of Achyranthis Bidentatae Radix on Osteoclast Differentiation and Bone Resorption  

Kim, Ju-Ho (Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Ki, Ji-Ye (Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Ann, Ji-Young (Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Park, Hye-Jung (Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Kim, Hyun-Ju (Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Kwak, Han-Bok (Department of Anatomy, School of Medicine, and Wonkwang Medical Science Institute, Wonkwang University)
Oh, Jae-Min (Department of Anatomy, School of Medicine, and Wonkwang Medical Science Institute, Wonkwang University)
Kim, Yun-Kyung (Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Publication Information
The Korea Journal of Herbology / v.25, no.1, 2010 , pp. 65-74 More about this Journal
Abstract
Objectives : Achyranthis Bidentatae Radix (ABR) has been used for treating of many symptoms especially osteoporosis and rheumatoid arthritis. In this study, we determined the effects of water extract of ABR in RANKL (Receptor Activator for Nuclear Factor $\kappa$ B Ligand)-induced osteoclast differentiation culture system. Methods : We assayed mRNA expression levels of NFATc1, c-Fos, TRAP, OSCAR, $FcR{\gamma}$, DAP12 and GAPDH in bone marrow macrophages (BMMs) treated with ABR. The protein expression levels of NFATc1, c-Fos, MAPKs and $\beta$-actin in cell lysates treated with ABR were analysed by Western blotting. In addition we determined the effects of water extract of ABR on LPS-induced bone-loss mouse. Results : Water extract of ABR showed remarkable inhibition on RANKL-treated osteoclast differentiation without cytotoxicity. ABR down-regulated the induction of c-Fos and NFATc1 by RANKL. ABR suppressed phosphorylation of JNK, p38 and I-${\kappa}B$. ABR rescued bone erosion by LPS induction in vivo study. Conclusions : These results demonstrate that ABR may be a useful remedy for curing of bone-loss disease such as osteoporosis.
Keywords
Achyranthis Bidentatae Radix; osteoclast differentiation; NFATc1; osteoporosis; RANKL;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Han KY, Yang D, Chang EJ, Lee Y, Hao Huang, Sung SH, Lee ZH, Kim YC, Kim HH. Inhibition of osteoclast differentiation and bone resorption by sauchinone. Biochemical Pharmacology. 2007 ; 74 : 911-23.   DOI   ScienceOn
2 Chen XM, Tian GY. Structural elucidation and antitumor activity of a fructan from Cyathula officinalis Kuan. Carbohydr Res. 2003 ; 338(11) : 1235-41.   DOI   ScienceOn
3 Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem. 2001 ; 276 : 49343-9.   DOI   ScienceOn
4 Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003 ; 3 : 859-68.   DOI   ScienceOn
5 Chesnut CH III, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004 ; 19 : 1241-9.   DOI   ScienceOn
6 Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA. 1999 ; 282 : 637-45.   DOI   ScienceOn
7 Ringe JD, Dorst A, Faber H, Ibach K, Sorenson F. Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroidinduced osteoporosis : results from a long-term comparative study. Osteoporos Int. 2003 ; 14 : 801-7.   DOI   ScienceOn
8 Kim Y, Sato K, Asagiri M, Morita I, Soma K, Takayanagi H. Contribution of NFATc1 to the transcriptional control of immunoreceptor OSCAR but not TREM-2 during osteoclastogenesis. J Biol Chem. 2005 ; 280 : 32905-13.   DOI   ScienceOn
9 Basu S, Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene. 1998 ; 17 : 3277-85.   DOI
10 Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002 ; 3 : 889-901.   DOI   ScienceOn
11 Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007 ; 22 : 465-75.   DOI   ScienceOn
12 Reginster JY, Burlet N. Osteoporosis : a still increasing prevalence. Bone. 2006 ; 38 : S4-S9.
13 Wagner EF, Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 2005 ; 208 : 126-40.   DOI   ScienceOn
14 Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology. 2002 ; 143 : 3105-13.   DOI   ScienceOn
15 Alliston T, Derynck R. Interfering with bone remodelling. Nature. 2002 ; 416 : 686-7.   DOI   ScienceOn
16 Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003 ; 423 : 337-42.   DOI   ScienceOn
17 Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M. Involvement of p38 mitogenactivated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of $NF-\kappa B$ ligand (RANKL). J Biol Chem. 2000 ; 275 : 31155-61.   DOI   ScienceOn
18 Kwak HB, Lee SW, Li YJ, Kim YA, Han SY, Jhon GJ, Kim HH, Lee ZH. Inhibitory of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH. Biochemical Pharmacology. 2004 ; 67 : 1239-48.   DOI   ScienceOn
19 Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E. Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA. 1999 ; 96 : 3540-5.   DOI   ScienceOn
20 National Osteoporosis Foundation. America's Bone Health. The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC : National Osteoporosis Foundation. 2002.
21 Rodan GA, Raisz LG, Bilezikian JP. Principles of bone biology. Pathophysiology of osteoporosis. 2002 ; 1275-89.
22 Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone. 2002 ; 30 : 71-7.
23 Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R. Osteopetrosis in mice lacking $NF_kB1$ and $NF_kB2$. Nat Med. 1997 ; 3 : 1285-9.   DOI   ScienceOn
24 Komarova SV, Pilkington MF, Weidema AF, Dixon SJ, Sims SM. RANK ligand-induced elevation of cytosolic $Ca^{2+}$ accelerates nuclear translocation of $NF_kB$ in osteoclasts. J Biol Chem. 2003 ; 278 : 8286-93.   DOI   ScienceOn
25 Dai XM. Targeted disruption of the mouse colonystimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 2002 ; 99 : 111-28.   DOI   ScienceOn
26 Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S. Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med. 2002 ; 347 : 175-84.   DOI   ScienceOn
27 Kobayashi T, Walsh PT, Walsh MC, Speirs KM, Chiffoleau E, King CG, Hancock WW, Caamano JH, Hunter CA, Scott P, Turka LA, Choi Y. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity. 2003 ; 19 : 353-63.   DOI   ScienceOn
28 Mocsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA. 2004 ; 101 : 6158-63.   DOI   ScienceOn
29 Suda K, Woo JT, Takami M, Sexton PM, Nagai K. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol. 2002 ; 190 : 101-8.   DOI   ScienceOn
30 Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000 ; 406 : 782-7.   DOI   ScienceOn
31 Yavropoulou MP, Yovos JG. Osteoclstogenesis Current knowledge and future perspectives. J Musculoskelet Neuronal Interact. 2008 ; 8(3) : 204-16.
32 Lu T, Mao C, Zhang L, Xu W. The research on analgestic and anti-inflammatory action of different processed products of Achyranthes bidentata. Zhong Yao Cai. 1997 ; 20(10) : 507-9.
33 Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001 ; 344 : 1434-41.   DOI   ScienceOn
34 Gao XY, Wang DW, Li FM. Determination of ecdysterone in Achyranthes Bidentata Bl and its activity promoting proliferation of osteoblast-like cells. Yao Xue Xue Bao. 2000 ; 35(11) : 868-70.
35 Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption. International Immunopharmacology. 2007 ; 7 : 1507-16.   DOI   ScienceOn
36 Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF. Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992 ; 360 : 741-5.   DOI   ScienceOn
37 Hiroshi Takayanagi. Amazing multifunctionality of calcineurin and NFAT signaling in bone homeostasis. BoneKEy-Osteovision. 2006 ; 3 : 28-31.   DOI
38 Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, Nogi Y. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem. 2004 ; 279 : 45969-79.   DOI   ScienceOn
39 Tsai HY, Lin HY, Fong YC, Wu JB, Chen YF, Tsuzuki, Tang CH. Paeonol inhibits RANKLinduced osteoclastogenesis by inhibiting ERK, p38 and $NF_kB$ pathway. European Journal of Pharmacology. 2008 ; 588 : 124-33.   DOI   ScienceOn
40 Juan Li, Hui Qi, Lian-Wen Qi, Ling Yi, Ping Li. Simultaneous determination of main phytoecdysones and triterpenoids in Radix Achyranthis Bidentatae by high-performance liquid chromatography with diode array-evaporative light scattering detectors and mass spectrometry. Analytica Chimica Acta. 2007 ; 596 : 264-72.   DOI   ScienceOn
41 Kwak HB, Kim JH, Kim DJ, Kwon YM, Oh JM, Kim YK. Effect of Water Extract of Deer Antler in Osteoclast Differentiation. Korean J Oriental Physiology & Pathology. 2008 ; 22(4) : 891-5.   과학기술학회마을
42 Darnay BG, Ni J, Moore PA, Aggarwal BB. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaBinducing kinase. Identification of a novel TRAF6 interaction motif. J Biol Chem. 1999 ; 274 : 7724-31.   DOI   ScienceOn
43 Lee ZH, Kim HH. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003 ; 305 : 211-4.   DOI   ScienceOn